Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 22;107(8):e3515–e3525. doi: 10.1210/clinem/dgac166

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 3. — Relationship between prolactin (PRL) levels of individuals at visit 2 and features of luteinizing hormone (LH) response to kisspeptin at visit 2 (n = 11). PRL level from visit 2 before kisspeptin administration (hour 0-hour 1) is included in this analysis. Pulse frequency, mean LH, and interpulse interval (IPI) were calculated across the time frame of kisspeptin administration (hour 1-hour 11). LH pulse amplitude from response to first kisspeptin bolus is included in this analysis. A, PRL vs pulse frequency; B, PRL vs LH pulse amplitude; C, PRL vs mean LH levels; and D, PRL vs IPI. Statistically significant P and R values are included in the figure.